{
    "Orphapacket": {
        "ORPHApacketId": "53347",
        "creationDate": "2025-06-26 11:48:15",
        "version": "1.3.42 / 4.1.8 [2025-03-03]",
        "copyright": "Orphanet (c) 2025",
        "ORPHAcode": "53347",
        "Label": "Brody myopathy",
        "PURL": "http://www.orpha.net/ORDO/Orphanet_53347",
        "DisorderType": {
            "value": "Disease",
            "PURL": "http://www.orpha.net/ORDO/Orphanet_377788"
        },
        "ExternalReferences": [
            {
                "Source": "OMIM",
                "Reference": "601003",
                "DisorderMappingRelation": "E (Exact mapping: the two concepts are equivalent)"
            }
        ],
        "TextSection": {
            "TextSectionType": "Definition",
            "Contents": "A rare genetic skeletal muscle disease characterized by childhood onset of exercise-induced progressive impairment of muscle relaxation stiffness cramps and myalgia predominantly in the arms legs and face (eyelids) and biochemically by a reduced sarcoplasmic reticulum Ca(2+)-ATPase activity. Symptoms improve after a few minutes of rest and may be exacerbated by cold. The term Brody syndrome refers to a clinically distinguishable subset of patients without <i>ATP2A1</i> mutations with adolescence or adult onset and selective muscular involvement in which myalgia is more common."
        },
        "Genes": [
            {
                "Gene": {
                    "Symbol": "ATP2A1",
                    "Name": "ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1",
                    "ExternalReferences": [
                        {
                            "Source": "HGNC",
                            "Reference": "811"
                        },
                        {
                            "Source": "OMIM",
                            "Reference": "108730"
                        },
                        {
                            "Source": "ClinVar",
                            "Reference": "ATP2A1"
                        }
                    ],
                    "DisorderGeneAssociationType": "Disease-causing germline mutation(s) (loss of function) in"
                }
            }
        ],
        "Parents": [
            {
                "Parent": [
                    {
                        "ORPHAcode": "206656",
                        "Label": "Non-dystrophic myopathy"
                    }
                ]
            },
            {
                "Parent": [
                    {
                        "ORPHAcode": "209199",
                        "Label": "Qualitative or quantitative defects of protein SERCA1"
                    }
                ]
            }
        ],
        "Prevalences": {
            "Prevalence": [
                {
                    "Source": "ORPHANET_32040565[PMID]_22704959[PMID]",
                    "PrevalenceType": "Point prevalence",
                    "PrevalenceQualification": "Class only",
                    "PrevalenceClass": "<1 / 1 000 000",
                    "ValMoy": "0.0",
                    "PrevalenceGeographic": "Worldwide"
                }
            ]
        },
        "AverageAgeOfOnsets": [
            {
                "AverageAgeOfOnset": {
                    "value": "Adolescent"
                }
            },
            {
                "AverageAgeOfOnset": {
                    "value": "Adult"
                }
            },
            {
                "AverageAgeOfOnset": {
                    "value": "Childhood"
                }
            }
        ],
        "TypeOfInheritances": [
            {
                "TypeOfInheritance": {
                    "value": "Autosomal dominant"
                }
            },
            {
                "TypeOfInheritance": {
                    "value": "Autosomal recessive"
                }
            }
        ]
    }
}